Shares of French biotech Abivax (ABVX) climbed in Paris on Wednesday, in a move Reuters attributed to market speculation about a potential takeover bid from weight-loss drugmaker Eli Lilly (LLY). The ...

Copyright (c) 2025 Dow Jones & Company, Inc. The articles, information, and content displayed on this webpage may include materials prepared and provided by third ...

Fifteen years after Animal and Cannibal, Kesha is finally feeling glittery again. Now that her long legal battle with producer Dr. Luke is over, she’s ready to reembrace her career breakthrough, which ...

Eli Lilly on Monday announced new price cuts for its popular weight loss drug Zepbound, broadening access for patients and driving greater use of the company’s digital healthcare platform, LillyDirect ...

Eli Lilly on Monday, Dec. 1 slashed prices of its blockbuster weight loss drug Zepbound for consumers who buy the prescription medication directly from the drugmaker. Lilly's price cuts ranged from ...

IT’S MORE THAN life-saving medicine. Lilly is a world premier medicine company, discovering innovative treatments to fight diseases like cancer, diabetes, and Alzheimer’s. Based in Indianapolis, Lilly ...

Both Eli Lilly and Novo Nordisk are denying a telehealth company’s claim of having struck partnerships with the two companies to provide direct access to their popular obesity meds. Thursday morning, ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Want to stay on top of ...

Eli Lilly stock reached a new 52-week high on Nov. 10, up 4.7% and extending a month-long rally of 16%, after the pharmaceutical giant announced two strategic deals, following the highly anticipated ...

Early results showed that patients lost up to 20.1% of their body weight. Eli Lilly's next generation of weight loss drugs appear to show promise, possibly leading to even faster weight loss and added ...

Eli Lilly has pulled out of the central nervous system (CNS)-focused portion of a $960 million biobucks deal centered on Rigel Pharmaceuticals’ receptor-interacting serine/threonine-protein kinase 1 ...

Eli Lilly is going for gold at the Milano Cortina 2026 Olympic and Paralympic Winter Games. In a pair of recent announcements, the Big Pharma was named an official sponsor of the Games, while also ...